Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.3929
+0.0059 (1.52%)
At close: Jan 8, 2026, 4:00 PM EST
0.4002
+0.0073 (1.86%)
After-hours: Jan 8, 2026, 7:41 PM EST
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $35.85 million as of January 8, 2026. Its market cap has decreased by -44.51% in one year.
Market Cap
35.85M
Enterprise Value
19.97M
1-Year Change
-44.51%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $35.85M, a decrease of -81.47%. That is a compound annual growth rate of -18.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 30.50M | 27.08% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.97B |
| UnitedHealth Group | 314.42B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.11B |
| Merck & Co. | 272.87B |
| Novo Nordisk | 254.60B |